New drug AGA2118 tested in healthy volunteers across ethnic groups
Knowledge-focused
Ongoing
This early-stage study is testing a single dose of a drug called AGA2118 in 30 healthy adults of Japanese, Chinese, and Caucasian backgrounds. Researchers want to see how the drug moves through the body and if it causes any side effects. The goal is to gather basic safety and dos…
Phase: PHASE1 • Sponsor: Angitia Incorporated Limited • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC